We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Genscriptdxd Antibody (39f4), Mab; 40ug
List Price $160.00 Your Price $160.00
GenScript Dxd Antibody (39f4), Mab, Mouse1mg - GSCRPT (Additional S&H or Hazmat Fees May Apply)
NETA PART: GSCRPT-A02217-40
MFG.PART: A02217-40
UNSPSC: 12352203
Manufacturer: GenScript USA Inc
Overview
| Specificity | The product is specific for DXd and DXd structurally similar molecules. The antibody can bind to DS-8201a. |
| Host Species | Mouse |
| Immunogen | DXd-KLH |
| Conjugate | Unconjugated |
Applications
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||
| |||||
Properties
| Form | Liquid |
| Storage Buffer | Supplied in PBS, pH 7.4, containing 0.02% ProClin300. |
| Concentration | 0.5 mg/mL |
| Storage Instructions | The product remains stable up to 1 year at -20 °C from date of receipt. Avoid repeated freezing and thawing cycles. |
| Purification | Protein A affinity column |
| Isotype | Mouse IgG2b, κ |
| Clonality | Monoclonal |
| Clone ID | 39F4 |
| Note | GenScript can customize this product per customers request including product size, buffer components, etc. |
Background
| Target Background | Payloads are the important components of antibody-drug conjugates (ADCs). The most commonly used ADC payloads are MMAE, DM1, and DXd. ADC pharmacokinetic (PK) studies include free payload analysis, conjugated antibody analysis, and total antibody analysis via ligand-binding assay (LBA) and LC-MS/MS assay. The anti-payload antibody is a useful reagent in PK assay for determining conjugated antibodies. It can be used as a capture antibody to determine the conjugated antibody in LBA assay or through immunocapture to enrich the ADC sample in LC-MS/MS assay. The DXd, also known as exatecan derivative, is a potent inhibitor of DNA topoisomerase I. Trastuzumab deruxtecan (T-DXd, DS-8201a or Enhertu®), composed of trastuzumab conjugated to DXd, is the first approved ADC for the treatment of breast cancer. |
| Synonyms | Dxd, OQM5SD32BQ, UNII-OQM5SD32BQ, Exatecan derivative, Exatecan derivative for ADC |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
| SKU | GSCRPT-A02217-40 |
|---|---|
| Supplier Part Number | A02217-40 |
| UM | EA |
| UNSPSC | 12352203 |
| Manufacturer | GenScript USA Inc |
| Temperature | The product remains stable up to 1 year at -20 °C from date of receipt. Avoid repeated freezing and thawing cycles. |
| ProductLine | GSCRPT |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 7 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |